# Gilboa Therapeutics

**Source:** https://www.startuphub.ai/startups/gilboa-therapeutics
**Profile type:** Startup

> Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology.

## About

Gilboa Therapeutics is a preclinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. Their mission is to enable more patients to respond to therapies and improve outcomes by harnessing the power of the patient's immune system with their proprietary SolidT technology.

## Key facts

- **Slug:** gilboa-therapeutics
- **Website:** https://www.gilboa.bio/
- **Location:** Tel Aviv, Israel
- **Founded:** 2017-01-01
- **Employees:** 2
- **Operating status:** Inactive
- **Sectors / tags:** Biopharmaceuticals, Immunotherapy, Cancer Treatment, Biotechnology, Biotech, Drug Discovery, Oncology, Clinical Trials
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/gilboa-therapeutics1/

## Frequently asked

### What does Gilboa Therapeutics do?

Gilboa Therapeutics is a preclinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. Their mission is to enable more patients to respond to therapies and improve outcomes by harnessing the power of the patient's immune system with their proprietary SolidT technology.

### Where is Gilboa Therapeutics headquartered?

Gilboa Therapeutics is headquartered in Tel Aviv, Israel.

### When was Gilboa Therapeutics founded?

Gilboa Therapeutics was founded in 2017.

### What industry does Gilboa Therapeutics operate in?

Gilboa Therapeutics operates in Biopharmaceuticals, Immunotherapy, Cancer Treatment, Biotechnology, Biotech, Drug Discovery.

### How many employees does Gilboa Therapeutics have?

Gilboa Therapeutics has approximately 2 people on record.

### What is Gilboa Therapeutics's current status?

Gilboa Therapeutics's current operating status is: Inactive.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Gilboa Therapeutics",
          "item": "https://www.startuphub.ai/startups/gilboa-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/gilboa-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/gilboa-therapeutics",
      "name": "Gilboa Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Gilboa Therapeutics. Gilboa Therapeutics is a startup founded in 2017, operating in Biopharmaceuticals and Immunotherapy. Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology. Headquartered in Tel Aviv, Israel. The company has approximately 2 employees.",
      "dateModified": "2026-06-21T09:32:37.935+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/gilboa-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/gilboa-therapeutics#organization",
      "name": "Gilboa Therapeutics",
      "url": "https://www.gilboa.bio/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/980531.jpeg",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/980531.jpeg",
      "description": "This is the official profile of Gilboa Therapeutics. Gilboa Therapeutics is a startup founded in 2017, operating in Biopharmaceuticals and Immunotherapy. Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology. Headquartered in Tel Aviv, Israel. The company has approximately 2 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/gilboa-therapeutics1/",
        "https://www.startuphub.ai/startups/gilboa-therapeutics"
      ],
      "foundingDate": "2017-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 2
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Tel Aviv",
        "addressCountry": "Israel"
      },
      "knowsAbout": [
        "Biopharmaceuticals",
        "Immunotherapy",
        "Cancer Treatment",
        "Biotechnology",
        "Biotech",
        "Drug Discovery",
        "Oncology",
        "Clinical Trials"
      ]
    }
  ]
}
```